Cargando…

A prospective clinical study on the mechanisms underlying critical illness myopathy—A time‐course approach

BACKGROUND: Critical illness myopathy (CIM) is a consequence of modern critical care resulting in general muscle wasting and paralyses of all limb and trunk muscles, resulting in prolonged weaning from the ventilator, intensive care unit (ICU) treatment and rehabilitation. CIM is associated with sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Cacciani, Nicola, Skärlén, Åsa, Wen, Ya, Zhang, Xiang, Addinsall, Alex B., Llano‐Diez, Monica, Li, Meishan, Gransberg, Lennart, Hedström, Yvette, Bellander, Bo‐Michael, Nelson, David, Bergquist, Jonas, Larsson, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745499/
https://www.ncbi.nlm.nih.gov/pubmed/36222215
http://dx.doi.org/10.1002/jcsm.13104
_version_ 1784849164467699712
author Cacciani, Nicola
Skärlén, Åsa
Wen, Ya
Zhang, Xiang
Addinsall, Alex B.
Llano‐Diez, Monica
Li, Meishan
Gransberg, Lennart
Hedström, Yvette
Bellander, Bo‐Michael
Nelson, David
Bergquist, Jonas
Larsson, Lars
author_facet Cacciani, Nicola
Skärlén, Åsa
Wen, Ya
Zhang, Xiang
Addinsall, Alex B.
Llano‐Diez, Monica
Li, Meishan
Gransberg, Lennart
Hedström, Yvette
Bellander, Bo‐Michael
Nelson, David
Bergquist, Jonas
Larsson, Lars
author_sort Cacciani, Nicola
collection PubMed
description BACKGROUND: Critical illness myopathy (CIM) is a consequence of modern critical care resulting in general muscle wasting and paralyses of all limb and trunk muscles, resulting in prolonged weaning from the ventilator, intensive care unit (ICU) treatment and rehabilitation. CIM is associated with severe morbidity/mortality and significant negative socioeconomic consequences, which has become increasingly evident during the current COVID‐19 pandemic, but underlying mechanisms remain elusive. METHODS: Ten neuro‐ICU patients exposed to long‐term controlled mechanical ventilation were followed with repeated muscle biopsies, electrophysiology and plasma collection three times per week for up to 12 days. Single muscle fibre contractile recordings were conducted on the first and final biopsy, and a multiomics approach was taken to analyse gene and protein expression in muscle and plasma at all collection time points. RESULTS: (i) A progressive preferential myosin loss, the hallmark of CIM, was observed in all neuro‐ICU patients during the observation period (myosin:actin ratio decreased from 2.0 in the first to 0.9 in the final biopsy, P < 0.001). The myosin loss was coupled to a general transcriptional downregulation of myofibrillar proteins (P < 0.05; absolute fold change >2) and activation of protein degradation pathways (false discovery rate [FDR] <0.1), resulting in significant muscle fibre atrophy and loss in force generation capacity, which declined >65% during the 12 day observation period (muscle fibre cross‐sectional area [CSA] and maximum single muscle fibre force normalized to CSA [specific force] declined 30% [P < 0.007] and 50% [P < 0.0001], respectively). (ii) Membrane excitability was not affected as indicated by the maintained compound muscle action potential amplitude upon supramaximal stimulation of upper and lower extremity motor nerves. (iii) Analyses of plasma revealed early activation of inflammatory and proinflammatory pathways (FDR < 0.1), as well as a redistribution of zinc ions from plasma. CONCLUSIONS: The mechanical ventilation‐induced lung injury with release of cytokines/chemokines and the complete mechanical silencing uniquely observed in immobilized ICU patients affecting skeletal muscle gene/protein expression are forwarded as the dominant factors triggering CIM.
format Online
Article
Text
id pubmed-9745499
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97454992022-12-14 A prospective clinical study on the mechanisms underlying critical illness myopathy—A time‐course approach Cacciani, Nicola Skärlén, Åsa Wen, Ya Zhang, Xiang Addinsall, Alex B. Llano‐Diez, Monica Li, Meishan Gransberg, Lennart Hedström, Yvette Bellander, Bo‐Michael Nelson, David Bergquist, Jonas Larsson, Lars J Cachexia Sarcopenia Muscle Original Articles BACKGROUND: Critical illness myopathy (CIM) is a consequence of modern critical care resulting in general muscle wasting and paralyses of all limb and trunk muscles, resulting in prolonged weaning from the ventilator, intensive care unit (ICU) treatment and rehabilitation. CIM is associated with severe morbidity/mortality and significant negative socioeconomic consequences, which has become increasingly evident during the current COVID‐19 pandemic, but underlying mechanisms remain elusive. METHODS: Ten neuro‐ICU patients exposed to long‐term controlled mechanical ventilation were followed with repeated muscle biopsies, electrophysiology and plasma collection three times per week for up to 12 days. Single muscle fibre contractile recordings were conducted on the first and final biopsy, and a multiomics approach was taken to analyse gene and protein expression in muscle and plasma at all collection time points. RESULTS: (i) A progressive preferential myosin loss, the hallmark of CIM, was observed in all neuro‐ICU patients during the observation period (myosin:actin ratio decreased from 2.0 in the first to 0.9 in the final biopsy, P < 0.001). The myosin loss was coupled to a general transcriptional downregulation of myofibrillar proteins (P < 0.05; absolute fold change >2) and activation of protein degradation pathways (false discovery rate [FDR] <0.1), resulting in significant muscle fibre atrophy and loss in force generation capacity, which declined >65% during the 12 day observation period (muscle fibre cross‐sectional area [CSA] and maximum single muscle fibre force normalized to CSA [specific force] declined 30% [P < 0.007] and 50% [P < 0.0001], respectively). (ii) Membrane excitability was not affected as indicated by the maintained compound muscle action potential amplitude upon supramaximal stimulation of upper and lower extremity motor nerves. (iii) Analyses of plasma revealed early activation of inflammatory and proinflammatory pathways (FDR < 0.1), as well as a redistribution of zinc ions from plasma. CONCLUSIONS: The mechanical ventilation‐induced lung injury with release of cytokines/chemokines and the complete mechanical silencing uniquely observed in immobilized ICU patients affecting skeletal muscle gene/protein expression are forwarded as the dominant factors triggering CIM. John Wiley and Sons Inc. 2022-10-12 2022-12 /pmc/articles/PMC9745499/ /pubmed/36222215 http://dx.doi.org/10.1002/jcsm.13104 Text en © 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Cacciani, Nicola
Skärlén, Åsa
Wen, Ya
Zhang, Xiang
Addinsall, Alex B.
Llano‐Diez, Monica
Li, Meishan
Gransberg, Lennart
Hedström, Yvette
Bellander, Bo‐Michael
Nelson, David
Bergquist, Jonas
Larsson, Lars
A prospective clinical study on the mechanisms underlying critical illness myopathy—A time‐course approach
title A prospective clinical study on the mechanisms underlying critical illness myopathy—A time‐course approach
title_full A prospective clinical study on the mechanisms underlying critical illness myopathy—A time‐course approach
title_fullStr A prospective clinical study on the mechanisms underlying critical illness myopathy—A time‐course approach
title_full_unstemmed A prospective clinical study on the mechanisms underlying critical illness myopathy—A time‐course approach
title_short A prospective clinical study on the mechanisms underlying critical illness myopathy—A time‐course approach
title_sort prospective clinical study on the mechanisms underlying critical illness myopathy—a time‐course approach
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745499/
https://www.ncbi.nlm.nih.gov/pubmed/36222215
http://dx.doi.org/10.1002/jcsm.13104
work_keys_str_mv AT caccianinicola aprospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach
AT skarlenasa aprospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach
AT wenya aprospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach
AT zhangxiang aprospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach
AT addinsallalexb aprospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach
AT llanodiezmonica aprospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach
AT limeishan aprospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach
AT gransberglennart aprospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach
AT hedstromyvette aprospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach
AT bellanderbomichael aprospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach
AT nelsondavid aprospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach
AT bergquistjonas aprospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach
AT larssonlars aprospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach
AT caccianinicola prospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach
AT skarlenasa prospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach
AT wenya prospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach
AT zhangxiang prospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach
AT addinsallalexb prospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach
AT llanodiezmonica prospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach
AT limeishan prospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach
AT gransberglennart prospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach
AT hedstromyvette prospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach
AT bellanderbomichael prospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach
AT nelsondavid prospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach
AT bergquistjonas prospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach
AT larssonlars prospectiveclinicalstudyonthemechanismsunderlyingcriticalillnessmyopathyatimecourseapproach